Zomedica Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Zomedica Pharmaceuticals Stock Summary

Zomedica Pharmaceuticals competes with Emergent Biosolutions, Bausch Health, Neurocrine Biosciences, Teva Pharma, and Haleon Plc. Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 47 people.

Zomedica Pharmaceuticals Key Financial Ratios

Zomedica Pharmaceuticals Key Balance Sheet Accounts

Zomedica Pharmaceuticals Key Income Statement Accounts

Zomedica Pharmaceuticals Key Cash Accounts

Zomedica Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zomedica Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Zomedica Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zomedica Pharmaceuticals competition to find correlations between indicators driving Zomedica Pharmaceuticals's intrinsic value. More Info.Zomedica Pharmaceuticals Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Zomedica Pharmaceuticals' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Zomedica Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Zomedica Pharmaceuticals Systematic Risk

Today, most investors in Zomedica Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zomedica Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Zomedica Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Zomedica Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zomedica Pharmaceuticals Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zomedica Pharmaceuticals Corp based on widely used predictive technical indicators. In general, we focus on analyzing Zomedica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zomedica Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.